Harmony Property Plant And Equipment Net from 2010 to 2024

HRMY Stock  USD 29.32  0.39  1.35%   
Harmony Biosciences Property Plant And Equipment Net yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Net will likely drop to about 352.4 K in 2024. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects Harmony Biosciences' investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2010-12-31
Previous Quarter
371 K
Current Value
352.4 K
Quarterly Volatility
484 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 25.6 M or Interest Expense of 17.9 M, as well as many exotic indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
This module can also supplement Harmony Biosciences' financial leverage analysis and stock options assessment as well as various Harmony Biosciences Technical models . Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of Harmony Biosciences Holdings over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. Harmony Biosciences' Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Slightly volatile
   Property Plant And Equipment Net   
       Timeline  

Harmony Property Plant And Equipment Net Regression Statistics

Arithmetic Mean1,237,897
Geometric Mean1,107,049
Coefficient Of Variation39.10
Mean Deviation418,004
Median1,576,000
Standard Deviation483,994
Sample Variance234.2B
Range1.2M
R-Value(0.87)
Mean Square Error63.1B
R-Squared0.75
Significance0.00003
Slope(93,714)
Total Sum of Squares3.3T

Harmony Property Plant And Equipment Net History

2024352.4 K
2023371 K
2022573 K
2021820 K
2020938 K
20191.3 M

About Harmony Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Harmony Biosciences income statement, its balance sheet, and the statement of cash flows. Harmony Biosciences investors use historical funamental indicators, such as Harmony Biosciences's Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although Harmony Biosciences investors may use each financial statement separately, they are all related. The changes in Harmony Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Harmony Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Harmony Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Net371 K352.4 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harmony Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harmony Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harmony Biosciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harmony Biosciences Holdings Stock:
Check out the analysis of Harmony Biosciences Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Harmony Stock analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Earnings Share
2.13
Revenue Per Share
9.787
Quarterly Revenue Growth
0.313
Return On Assets
0.1616
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.